A Geisel-led study reveals that there is substantial variation across different regions of the country in the intensity of fracture-associated drug use among long-term care residents, and that areas with greater use of these prescription drugs experience higher fracture rates.
The American Society for Microbiology has named George O’Toole, PhD, The Elmer R. Pfefferkorn, Ph.D. Professor of Microbiology & Immunology at Geisel, as editor-in-chief of The Journal of Bacteriology effective July 1, 2021.
A new collaborative study from researchers at the Geisel School of Medicine at Dartmouth and the University of Washington and published in the Proceedings of the National Academy of Sciences (PNAS), reveals unexpected insights into how skin exposure to ultraviolet light can worsen clinical symptoms in autoimmune diseases such as lupus.
Dartmouth researchers convert a standard linear accelerator used for delivery of radiation therapy cancer treatment, to deliver an ultra-high-dose rate radiation therapy beam to patients “in a flash.”
Discoveries originating in a basic science lab at the Geisel School of Medicine are being used in the newly approved COVID-19 vaccine from the Pfizer/BioNTech partnership.
New findings published by Dartmouth researchers and featured in a special issue of Health Services Research, are helping to generate new insights and knowledge about the prevalence, roles, and impact of integrated health systems.
A new article, published in the American Journal of Preventive Medicine by a by a team of researchers and advocates including Dartmouth faculty, asserts that current gaps in the regulation of commercial educational websites are exposing children to unhealthy food marketing. The group is working with major food companies and the USDA to limit these practices.
Results from a new study co-led by researchers at Dartmouth’s Geisel School of Medicine and the Department of Surgery at Kuma Hospital in Kobe, Japan, show that active surveillance can be successfully implemented as a viable treatment option for patients with low-risk thyroid cancer.
Steven L. Bernstein, MD, has been named as the inaugural Chief Research Officer for Dartmouth-Hitchcock (D-H), Associate Dean of Clinical Research at the Geisel School of Medicine at Dartmouth, and Director of the C. Everett Koop Institute at Geisel.
A team of researchers led by Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has identified mammary basal cells as a contributing source to the development of heterogeneous tumor cell subpopulations and found that activation of the PKA signaling pathway can curtail their emergence, providing opportunities for new therapeutic approaches to breast cancer.